Total Payments
$2,114
2022 Payments
$475.17
Companies
13
Transactions
85
Medicare Patients
170
Medicare Billing
$24,697
Payment Breakdown by Category
Food & Beverage$1,854 (87.7%)
Education$259.10 (12.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,854 | 78 | 87.7% |
| Education | $259.10 | 7 | 12.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $763.31 | 35 | $0 (2020) |
| Alkermes, Inc. | $332.53 | 12 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $202.51 | 10 | $0 (2022) |
| ITI, Inc. | $174.66 | 6 | $0 (2022) |
| Shire North American Group Inc | $163.93 | 4 | $0 (2019) |
| Tris Pharma Inc | $105.88 | 1 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $103.11 | 2 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $74.33 | 4 | $0 (2021) |
| Neurocrine Biosciences, Inc. | $58.57 | 3 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $55.47 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $475.17 | 17 | Janssen Pharmaceuticals, Inc ($172.96) |
| 2021 | $318.23 | 7 | Alkermes, Inc. ($164.03) |
| 2020 | $118.66 | 7 | Neurocrine Biosciences, Inc. ($42.80) |
| 2019 | $773.30 | 36 | Allergan Inc. ($524.25) |
| 2018 | $428.14 | 18 | Allergan Inc. ($227.53) |
All Payment Transactions
85 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/21/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: PSYCHIATRY | ||||||
| 09/28/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $118.58 | General |
| Category: PSYCHIATRY | ||||||
| 08/30/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: CNS | ||||||
| 08/16/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: Neuroscience | ||||||
| 08/11/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: PSYCHIATRY | ||||||
| 08/11/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $0.36 | General |
| Category: PSYCHIATRY | ||||||
| 07/14/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $5.94 | General |
| Category: PSYCHIATRY | ||||||
| 07/12/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: BH | ||||||
| 06/09/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: Neuroscience | ||||||
| 06/07/2022 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $88.49 | General |
| 05/10/2022 | Janssen Pharmaceuticals, Inc | INVEGA TRINZA (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: Neuroscience | ||||||
| 05/10/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $0.69 | General |
| Category: Neuroscience | ||||||
| 05/09/2022 | Janssen Pharmaceuticals, Inc | INVEGA TRINZA (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $1.67 | General |
| Category: Neuroscience | ||||||
| 04/06/2022 | Janssen Pharmaceuticals, Inc | INVEGA TRINZA (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $102.33 | General |
| Category: Neuroscience | ||||||
| 04/06/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: BH | ||||||
| 03/11/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA, INVEGA | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Neuroscience | ||||||
| 02/14/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $8.63 | General |
| Category: Neuroscience | ||||||
| 10/16/2021 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $105.88 | General |
| Category: ADHD | ||||||
| 04/22/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: CNS | ||||||
| 04/21/2021 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: PSYCHIATRY | ||||||
| 04/19/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: NEUROSCIENCE | ||||||
| 03/31/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: CNS | ||||||
| 03/25/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
| 01/22/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Education | In-kind items and services | $14.62 | General |
| Category: Central Nervous System | ||||||
| 12/07/2020 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 64 | 175 | $44,075 | $12,321 |
| 2021 | 1 | 18 | 31 | $9,624 | $1,667 |
| 2020 | 3 | 88 | 171 | $56,173 | $10,709 |
Total Patients
170
Total Services
377
Medicare Billing
$24,697
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 73 | $19,641 | $6,209 | 31.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 47 | 102 | $24,434 | $6,112 | 25.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 18 | 31 | $9,624 | $1,667 | 17.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 24 | 67 | $20,799 | $5,482 | 26.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 24 | 25 | $18,486 | $2,442 | 13.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 26 | 46 | $14,280 | $1,821 | 12.8% |
| G0406 | Follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth | Facility | 2020 | 14 | 33 | $2,607 | $963.69 | 37.0% |
About Dr. Robert Portley, M.D
Dr. Robert Portley, M.D is a Psychiatry healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2013. The National Provider Identifier (NPI) number assigned to this provider is 1417299819.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Portley, M.D has received a total of $2,114 in payments from pharmaceutical and medical device companies, with $475.17 received in 2022. These payments were reported across 85 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,854).
As a Medicare-enrolled provider, Portley has provided services to 170 Medicare beneficiaries, totaling 377 services with total Medicare billing of $24,697. Data is available for 3 years (2020–2022), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Child & Adolescent Psychiatry, Student in an Organized Health Care Education/Training Program
- Location Omaha, NE
- Active Since 03/23/2013
- Last Updated 02/08/2021
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1417299819
Products in Payments
- VRAYLAR (Drug) $783.11
- ARISTADA (Drug) $281.74
- CAPLYTA (Drug) $174.66
- MYDAYIS (Drug) $119.67
- INVEGA TRINZA (Drug) $109.15
- Dyanavel XR (Drug) $105.88
- INVEGA SUSTENNA (Drug) $93.36
- INGREZZA (Drug) $58.57
- Trintellix (Drug) $55.47
- Aristada 441 mg (Drug) $50.79
- VYVANSE (Drug) $44.26
- REXULTI (Drug) $42.40
- PERSERIS (Drug) $36.08
- ABILIFY MAINTENA (Drug) $31.93
- Fanapt (Drug) $23.32
- AUSTEDO (Drug) $14.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Omaha
Vithyalakshmi Selvaraj, M.b.b.s, M.B.B.S
Psychiatry — Payments: $1.2M
Psychiatry $1.2M
Dr. Sarit Hovav, M.d, M.D
Psychiatry — Payments: $467,341
Psychiatry $467,341
Mary Jo Hanigan, Md, MD
Psychiatry — Payments: $123,744
Psychiatry $123,744
Dr. Michael Sedlacek, Md, MD
Psychiatry — Payments: $21,436
Psychiatry $21,436
Syed Sattar, M.d, M.D
Psychiatry — Payments: $17,220
Psychiatry $17,220
Dr. Elizabeth Fitzpatrick, M.d, M.D
Psychiatry — Payments: $11,881
Psychiatry $11,881